Introduction: In this study, we investigated the effect of intravenous ketamine administration on the treatment of acute abdominal pain in lead poisoning patients. Methods: In this cross sectional study, we evaluated 20 patients with opium abuse with acute abdominal pain. With cardiac monitoring, 0.25 mg/kg ketamine (maximum dose was considered as 20 milligrams) was administered during 30 to 60 seconds. To control ketamine complications 0.03 mg/kg midazolam (maximum dose was considered as 2 milligrams) was injected slowly during one or two minutes. Patients were observed in the ED for the next 6 hours. Pain score was assessed based on VAS with a serial method, before ketamine administration, every hour for the next two hours and every two hours for four hours. Results: In this study 20 patients were enrolled with mean age of 37.2 ± 4.2 years (range from 30 to 44 yrs.). Repeated measurement test shows significant reduce in pain score after ketamine administration (P=0.001). Five patients report no pain 4 hours after ketamine injection, and 3 of them left the hospital with personal consent. From 17 remaining patients, 13 ones (76.4%) had no pain, and mean VAS score in other 4 patients was 1 or 2. Conclusion: our results show that single dose injectable ketamine is one of the best methods with the least side effects to alleviate acute abdominal pain in patients with drug abuse.
| Published in | Clinical Medicine Research (Volume 12, Issue 1) |
| DOI | 10.11648/j.cmr.20231201.12 |
| Page(s) | 9-12 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Acute Abdominal Pain, Lead Poisoning Patients, Ketamine
| [1] | Norouzi M, Eskandarion M R, Zargar Y. Death Due to Acute Poisoning with High Dose of Lead in an Opium Addict: A Case Report. Iran J Forensic Med. 2017; 23 (2): 142-146. |
| [2] | Verheij J, Voortman J, van Nieuwkerk C, Jarbandhan S, Mulder C, Bloemena E. Hepatic Morphopathologic findings of lead poisoning in a drug addict: A case report. J Gastrointestin Liver Dis. 2009; 18 (2): 225-7. |
| [3] | Pourmand A, Mazer-Amirshahi M, Royall C, Alhawas R, Shesser R. Low dose ketamine use in the emergency department, a new direction in pain management. Am J Emerg Med. 2017 Jun; 35 (6): 918-921. doi: 10.1016/j.ajem.2017.03.005. Epub 2017 Mar 2. |
| [4] | Sin B, Ternas T, Motov SM. The use of subdissociative-dose ketamine for acute pain in the emergency department. Acad Emerg Med. 2015 Mar; 22 (3): 251-7. doi: 10.1111/acem.12604. Epub 2015 Feb 25. |
| [5] | Sheikh S, Hendry P. The Expanding Role of Ketamine in the Emergency Department. Drugs. 2018 May; 78 (7): 727-735. doi: 10.1007/s40265-018-0904-8. |
| [6] | Nichols KA, Paciullo CA. Subdissociative Ketamine Use in the Emergency Department. Adv Emerg Nurs J. 2019 Jan/Mar; 41 (1): 15-22. doi: 10.1097/TME.0000000000000222. |
| [7] | Salman-Roghani H, Foroozan A. Lead poisoning, report of an interesting case. Govaresh. 2011; 14 (1): 39-46. |
| [8] | Shariat Moharari R, Khajavi M, Panahkhahi M, Mojtahedzadeh M, Najafi A. Loss of consciousness secondary to lead poisoning. MEJ ANESTH. 2009; 20 (3): 453-6. |
| [9] | Niesters M, Martini C, Dahan A. Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol. 2014 Feb; 77 (2): 357-67. doi: 10.1111/bcp.12094. |
| [10] | Iacobucci GJ, Visnjevac O, Pourafkari L, Nader ND. Ketamine: An Update on Cellular and Subcellular Mechanisms with Implications for Clinical Practice. Pain Physician. 2017 Feb; 20 (2): E285-E301. |
| [11] | Miracle VA. Lead Poisoning in Children and Adults. Dimens Crit Care Nurs. 2017 Jan/Feb; 36 (1): 71-73. |
| [12] | Hanna-Attisha M, Lanphear B, Landrigan P. Lead Poisoning in the 21st Century: The Silent Epidemic Continues. Am J Public Health. 2018 Nov; 108 (11): 1430. doi: 10.2105/AJPH.2018.304725. |
| [13] | Mottier DM, Cargnel E. [Abdominal pain as a presentation by lead poisoning. Case report]. Arch Argent Pediatr. 2017 Apr 1; 115 (2): e96-e98. doi: 10.5546/aap.2017.e96. |
| [14] | Renfrew D. Lead Poisoning and the Dangers of Pragmatism. Int J Environ Res Public Health. 2018 Sep 13; 15 (9). pii: E1997. doi: 10.3390/ijerph15091997. |
| [15] | Agency for Toxic Substances and Disease Registry. Interaction profile for chlorpyrifos, lead, mercury, and methylmercury. Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2006. http://www.atsdr.cdc.gov/interactionprofiles/IP-11/ip11.pdf. June 14, 2007. |
| [16] | Mongolu S, Sharp P. Acute abdominal pain and constipation due to lead poisoning. Acute Med. 2013; 12 (4): 224-6. |
APA Style
Shaghayegh Rahmani, Rana Kolahi Ahari, Hamed Shokoohsaremi, Roohie Farzaneh, Mohammad Davood Sharifi. (2023). Ketamine in Acute Abdominal Pain in Patients with Lead Poisoning. Clinical Medicine Research, 12(1), 9-12. https://doi.org/10.11648/j.cmr.20231201.12
ACS Style
Shaghayegh Rahmani; Rana Kolahi Ahari; Hamed Shokoohsaremi; Roohie Farzaneh; Mohammad Davood Sharifi. Ketamine in Acute Abdominal Pain in Patients with Lead Poisoning. Clin. Med. Res. 2023, 12(1), 9-12. doi: 10.11648/j.cmr.20231201.12
AMA Style
Shaghayegh Rahmani, Rana Kolahi Ahari, Hamed Shokoohsaremi, Roohie Farzaneh, Mohammad Davood Sharifi. Ketamine in Acute Abdominal Pain in Patients with Lead Poisoning. Clin Med Res. 2023;12(1):9-12. doi: 10.11648/j.cmr.20231201.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cmr.20231201.12,
author = {Shaghayegh Rahmani and Rana Kolahi Ahari and Hamed Shokoohsaremi and Roohie Farzaneh and Mohammad Davood Sharifi},
title = {Ketamine in Acute Abdominal Pain in Patients with Lead Poisoning},
journal = {Clinical Medicine Research},
volume = {12},
number = {1},
pages = {9-12},
doi = {10.11648/j.cmr.20231201.12},
url = {https://doi.org/10.11648/j.cmr.20231201.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20231201.12},
abstract = {Introduction: In this study, we investigated the effect of intravenous ketamine administration on the treatment of acute abdominal pain in lead poisoning patients. Methods: In this cross sectional study, we evaluated 20 patients with opium abuse with acute abdominal pain. With cardiac monitoring, 0.25 mg/kg ketamine (maximum dose was considered as 20 milligrams) was administered during 30 to 60 seconds. To control ketamine complications 0.03 mg/kg midazolam (maximum dose was considered as 2 milligrams) was injected slowly during one or two minutes. Patients were observed in the ED for the next 6 hours. Pain score was assessed based on VAS with a serial method, before ketamine administration, every hour for the next two hours and every two hours for four hours. Results: In this study 20 patients were enrolled with mean age of 37.2 ± 4.2 years (range from 30 to 44 yrs.). Repeated measurement test shows significant reduce in pain score after ketamine administration (P=0.001). Five patients report no pain 4 hours after ketamine injection, and 3 of them left the hospital with personal consent. From 17 remaining patients, 13 ones (76.4%) had no pain, and mean VAS score in other 4 patients was 1 or 2. Conclusion: our results show that single dose injectable ketamine is one of the best methods with the least side effects to alleviate acute abdominal pain in patients with drug abuse.},
year = {2023}
}
TY - JOUR T1 - Ketamine in Acute Abdominal Pain in Patients with Lead Poisoning AU - Shaghayegh Rahmani AU - Rana Kolahi Ahari AU - Hamed Shokoohsaremi AU - Roohie Farzaneh AU - Mohammad Davood Sharifi Y1 - 2023/03/28 PY - 2023 N1 - https://doi.org/10.11648/j.cmr.20231201.12 DO - 10.11648/j.cmr.20231201.12 T2 - Clinical Medicine Research JF - Clinical Medicine Research JO - Clinical Medicine Research SP - 9 EP - 12 PB - Science Publishing Group SN - 2326-9057 UR - https://doi.org/10.11648/j.cmr.20231201.12 AB - Introduction: In this study, we investigated the effect of intravenous ketamine administration on the treatment of acute abdominal pain in lead poisoning patients. Methods: In this cross sectional study, we evaluated 20 patients with opium abuse with acute abdominal pain. With cardiac monitoring, 0.25 mg/kg ketamine (maximum dose was considered as 20 milligrams) was administered during 30 to 60 seconds. To control ketamine complications 0.03 mg/kg midazolam (maximum dose was considered as 2 milligrams) was injected slowly during one or two minutes. Patients were observed in the ED for the next 6 hours. Pain score was assessed based on VAS with a serial method, before ketamine administration, every hour for the next two hours and every two hours for four hours. Results: In this study 20 patients were enrolled with mean age of 37.2 ± 4.2 years (range from 30 to 44 yrs.). Repeated measurement test shows significant reduce in pain score after ketamine administration (P=0.001). Five patients report no pain 4 hours after ketamine injection, and 3 of them left the hospital with personal consent. From 17 remaining patients, 13 ones (76.4%) had no pain, and mean VAS score in other 4 patients was 1 or 2. Conclusion: our results show that single dose injectable ketamine is one of the best methods with the least side effects to alleviate acute abdominal pain in patients with drug abuse. VL - 12 IS - 1 ER -
Email: